Skip to main content
Equibles
CTKB logo

CTKB · Cytek Biosciences, Inc. · Earnings Call Transcripts & Audio

Track CTKB — free

Use CTKB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CTKB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.73 +0.11 (+2.38%) At close · Sep 9
Russell 2000 member Rebalance outlook locked
Market Cap
$600.52M
Shares
129.98M

Cytek Biosciences, Inc. Earnings Call Transcripts

Quarterly earnings calls for Cytek Biosciences, Inc. (CTKB), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲17.7% $40.48M $1.63M '22 Q3 22-11-09 · $ $3.72M '22 Q4 23-02-28 ▲5.8% $37.09M −$6.81M '23 Q1 23-05-09 ▲23.7% $49.69M −$4.39M '23 Q2 23-08-08 ▲18.6% $48.00M −$6.46M '23 Q3 23-11-09 · $58.23M $5.50M '23 Q4 24-03-01 ▲21% $44.86M −$6.17M '24 Q1 24-05-08 ▼6.2% $46.62M −$10.43M '24 Q2 24-08-06 ▲7.3% $51.50M $941,000 '24 Q3 24-11-05 ▼1.3% $57.48M $9.64M '24 Q4 25-01-15 ▼7.6% $41.46M −$11.40M '25 Q1 25-05-08 ▼2.2% $45.60M −$5.58M '25 Q2 25-08-14 ▲1.5% $52.29M −$5.48M '25 Q3 25-11-05 ▲8.1% $62.14M −$44.08M '25 Q4 26-02-26 ▲6.5% $44.13M −$18.87M '26 Q1 26-05-07 LATEST ▲5.6% $48.14M −$12.16M '26 Q2 26-08-05
Conference
Investor event
2026-09-16
Cytek Biosciences, Inc. (CTKB) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
Cytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call Transcript
Positive tone Reorganization into business units Gross margin and tariff refund Recurring revenue (service and reagents)
Revenue
$48.14M
▲ 5.6% YoY
Gross margin
58.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript
Positive tone Q1 revenue and growth Geographic performance Recurring revenue (reagents and service)
Revenue
$44.13M
▲ 6.5% YoY
Gross margin
48.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript
Positive tone Quarterly and annual revenue performance 2026 financial guidance and outlook Geographic performance and end markets
Revenue
$62.14M*
▲ 8.1% YoY
Gross margin
52.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript
Positive tone Geographic revenue performance Recurring revenue growth (service and reagents) Capital deployment and M&A
Revenue
$52.29M
▲ 1.5% YoY
Gross margin
52.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript
Balanced tone Recurring revenue (reagents and service) Revenue performance and geographic mix Gross margin drivers and one-time items
Revenue
$45.60M
▼ 2.2% YoY
Gross margin
52.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript
Cautious tone Service and reagent recurring revenue APAC and rest of world growth Tariffs and macro environment
Revenue
$41.46M
▼ 7.6% YoY
Gross margin
48.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-15
Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Call Transcript
Positive tone Adjusted EBITDA and profitability leverage Cytek Cloud and bioinformatics China demand and stimulus
Revenue
$57.48M*
▼ 1.3% YoY
Gross margin
58.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript
Positive tone Instrument placements International growth (EMEA, APAC, China) Bioinformatics / Cytek Cloud
Revenue
$51.50M
▲ 7.3% YoY
Gross margin
56.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript
Balanced tone Product launches (ESP and spectral panel tool) U.S. market weakness and elongated sales cycles Installed base and replacement opportunity
Revenue
$46.62M
▼ 6.2% YoY
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript
Positive tone Luminex/Amnis/Guava integration Organic revenue growth and resumption Wuxi manufacturing facility
Revenue
$44.86M
▲ 21% YoY
Gross margin
51.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-01
Cytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcript
Positive tone Luminex/Amnis/Guava acquisition integration Geographic footprint and regions Revenue growth and 2023 results
Revenue
$58.23M*
Gross margin
56.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Cytek Biosciences, Inc. (CTKB) Q3 2023 Earnings Call Transcript
Revenue
$48.00M
▲ 18.6% YoY
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Cytek Biosciences, Inc. (CTKB) Q2 2023 Earnings Call Transcript
Revenue
$49.69M
▲ 23.7% YoY
Gross margin
56.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Cytek Biosciences, Inc. (CTKB) Q1 2023 Earnings Call Transcript
Revenue
$37.09M
▲ 5.8% YoY
Gross margin
56.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Cytek Biosciences, Inc. (CTKB) Q4 2022 Earnings Call Transcript
Revenue
$*
Gross margin
-26.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Cytek Biosciences, Inc. (CTKB) Q3 2022 Earnings Call Transcript
Revenue
$40.48M
▲ 17.7% YoY
Diluted EPS
$-0.01
Gross margin
66.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Cytek Biosciences, Inc. (CTKB) Q2 2022 Earnings Call Transcript
Revenue
$40.16M
▲ 32.1% YoY
Diluted EPS
$0.00
Gross margin
61.2%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Cytek Biosciences, Inc. (CTKB) Q1 2022 Earnings Call Transcript
Revenue
$35.06M
▲ 44.5% YoY
Diluted EPS
$0.02
Gross margin
57.5%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Cytek Biosciences, Inc. (CTKB) Q4 2021 Earnings Call Transcript
Revenue
$*
Gross margin
-27.2%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Cytek Biosciences, Inc. (CTKB) Q3 2021 Earnings Call Transcript
Revenue
$34.38M
▲ 37% YoY
Diluted EPS
$0.00
▼ 100% YoY
Gross margin
61.9%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–21 of 21 earnings calls
Key facts CIK 1831915 CUSIP 23285D109 13F (30d) 100 filings 99 filers Visit website Investor relations